{
    "root": "d949bc02-3337-4e86-99bc-287907e2330c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Fluocinonide Cream",
    "value": "20250513",
    "ingredients": [
        {
            "name": "FLUOCINONIDE",
            "code": "2W4A77YPAN"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "1,2,6-HEXANETRIOL",
            "code": "W45XXM0XWE"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "STEARYL ALCOHOL",
            "code": "2KR89I4H1Y"
        }
    ],
    "indications": "fluocinonide cream usp , 0.05 % indicated relief inflammatory pruritic manifestations corticosteroid-responsive dermatoses .",
    "contraindications": "fluocinonide cream usp , 0.05 % generally applied affected area thin film two four times daily depending severity condition . occlusive dressings may used management psoriasis recalcitrant conditions . infection develops , occlusive dressings discontinued appropriate antimicrobial therapy instituted .",
    "warningsAndPrecautions": "fluocinonide cream usp , 0.05 % supplied 30 g ( ndc 68788-8105-3 ) store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . preserve collapsible tubes tight containers . distributed : amneal pharmaceuticals llc bridgewater , nj 08807 rev . 04-2018-00 relabeled : preferred pharmaceuticals inc .",
    "adverseReactions": "topical corticosteroids contraindicated patients history hypersensitivity components preparations .",
    "indications_original": "Fluocinonide Cream USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.",
    "contraindications_original": "Fluocinonide Cream USP, 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.\n                  Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.\n                  If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions_original": "Fluocinonide Cream USP, 0.05% is supplied in 30 g (NDC 68788-8105-3)\n                  \n                     Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Preserve in collapsible tubes or tight containers. \n                  Distributed by:\n                     Amneal Pharmaceuticals LLC\n                     Bridgewater, NJ 08807\n                  Rev. 04-2018-00\n                  \n                     Relabeled By: Preferred Pharmaceuticals Inc.",
    "adverseReactions_original": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations."
}